Two Sigma Securities’s Charles River Laboratories CRL Stock Holding History

Two Sigma Securities’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,300	Closed	-$894K	–	3086
2024 Q1	$894K	Buy	3,300 +2,100	+175%	+$501K	0.01%	1207
2023 Q4	$284K	Sell	1,200 -2,600	-68%	-$511K	﹤0.01%	2048
2023 Q3	$745K	Buy	3,800 +2,100	+124%	+$431K	0.01%	1240
2023 Q2	$357K	Buy	1,700 +600	+55%	+$119K	0.01%	1719
2023 Q1	$222K	Buy	1,100 +100	+10%	+$22.7K	﹤0.01%	1993
2022 Q4	$218K	Sell	1,000 -1,800	-64%	-$393K	0.01%	1867
2022 Q3	$551K	Buy	+2,800	New	+$604K	0.02%	1025
2022 Q2	–	Sell	-1,400	Closed	-$398K	–	2306
2022 Q1	$398K	Buy	+1,400	New	+$432K	0.01%	1185

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Two Sigma Securities's CRL Position: Q3 2025 in Review

Two Sigma Securities sold out of Charles River Laboratories (CRL) in Q3 2025, closing a stake of 4,996 shares — an estimated $758K sold.

Two Sigma Securities first reported a position in CRL in Q4 2018 and held it in 10 quarters. The position peaked at $758K in Q2 2025. 556 funds tracked by Wall St. Rank hold CRL as of Q3 2025.

Two Sigma Securities reported no remaining Charles River Laboratories position as of Q3 2025 after selling out during the quarter.
Two Sigma Securities sold 4,996 Charles River Laboratories shares in Q3 2025, an estimated $758K.
Two Sigma Securities first reported a position in Charles River Laboratories in Q4 2018 and held it in 10 quarters.
Two Sigma Securities's Charles River Laboratories position peaked at $758K in Q2 2025.
556 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2025.

Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.